Nicotinamide adenine dinucleotide phosphate oxidase: A promiscuous therapeutic target for cardiovascular drugs?

Trends in Cardiovascular Medicine

Volumn 15, Issue 8, 2005, Pages 278-282

  Muzaffar, Saima ^a   Shukla, Nilima ^a   Jeremy, Jamie Y ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; ANTIOXIDANT; APOCYNIN; CORTICOSTEROID DERIVATIVE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; DIPHENYL IODONIUM CHLORIDE; DIPHENYLAMINE DERIVATIVE; ENZYME INHIBITOR; ICOSANOID; ILOPROST; MORPHOLINOSYDNONIMINE; NITRIC OXIDE DONOR; PHOSPHODIESTERASE INHIBITOR; PREDNISOLONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE INHIBITOR; SILDENAFIL; SILDENAFIL NITRATE; SUPEROXIDE; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ERECTILE DYSFUNCTION; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; REVIEW; STOMACH EROSION; VASCULAR DISEASE;

CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; EICOSANOIDS; GLUCOCORTICOIDS; HUMANS; IMPOTENCE; MALE; NADPH OXIDASE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; UP-REGULATION;

EID: 27744500822     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2005.09.001     Document Type: Review

References (46)

1. EH Awtry, and J Loscalzo Aspirin Circulation 101 2000 1206 1218
2. B Barbior Phagocytes and oxidative stress Am J Med 109 2000 33 44
3. RA Beswick, AM Dorrance, R Leite, and RC Webb NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat Hypertension 38 2001 1107 1111
4. T Bleeke, H Zhang, and N Madamanchi Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species Circ Res 94 2004 37 45
5. GJ Brewer Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation J Cell Mol Med 7 2003 11 20
6. H Cai, KK Griendling, and DG Harrison The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases Trends Pharmacol Sci 24 2003 471 478
7. MA Cotter, and NE Cameron Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats Life Sci 73 2003 1813 1824
8. F Dong, X Zhang, and LE Wold Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: Role of ET(B) receptor, NADPH oxidase and caveolin-1 Br J Pharmacol 145 2005 323 333
9. KK Griendling, CA Minieri, JD Ollerenshaw, and RW Alexander Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells Circ Res 74 1994 1114 1148
10. KK Griendling, D Sorescu, and M Ushio-Fukai NADPH oxidase role in cardiovascular biology and disease Circ Res 86 2000 494 501
11. AW Griffioen, and G Molema Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation Pharmacol Rev 52 2000 237 268
12. TZ Guzik, NEJ West, and E Black Vascular superoxide production by NAD(P)H oxidase: Association with endothelial dysfunction and clinical risk factors Circ Res 86 2000 E85 E90
13. T Hayashi, PA Juliet, and H Kano-Hayashi NADPH oxidase inhibitor, apocynin, restores the impaired endothelial-dependent and -independent responses and scavenges superoxide anion in rats with type 2 diabetes complicated by NO dysfunction Diabetes Obes Metab 7 2005 334 343
14. JM Isner Vascular endothelial growth factor: Gene therapy and therapeutic angiogenesis Am J Cardiol 82 1998 63S 64S
15. GM Jacobson, HM Dourron, and J Liu Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery Circ Res 92 2003 637 643
16. 2 synthesis Eur J Pharmacol 107 1985 259 262
17. JY Jeremy, D Mehta, AJ Bryan, and GD Angelini Platelets and saphenous vein graft failure Platelets 8 1997 295 309
18. JY Jeremy, D Rowe, AM Emsley, and AC Newby Nitric oxide and vascular smooth muscle cell proliferation Cardiovasc Res 43 1999 658 665
19. JY Jeremy, AP Yim, S Wan, and GD Angelini Oxidative stress, nitric oxide and vascular disease Cardiovasc Surg 17 2002 324 327
20. F Jiang, GR Drummond, and GJ Dusting Suppression of oxidative stress in endothelial and vascular wall Endothelium 111 2004 79 88
21. O Jung, JG Schreiber, and H Geiger gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension Circulation 109 2004 1795 1801
22. AM Kamal, RJ Flower, and M Perretti An overview of the effects of annexin 1 on cells involved in the inflammatory process Mem Inst Oswaldo Cruz 100 Suppl 1 2005 39 47
23. 2 mimetic, U46619, in corpus cavernosal smooth muscle cells Br J Urol 96 2005 423 427
24. D Krex, A Ziegler, and IR Konig Polymorphisms of the NADPH oxidase P22PHOX gene in a Caucasian population with intracranial aneurysms Cerebrovasc Dis 16 2003 363 368
25. JM Li, and AM Shah Endothelial cell superoxide generation: Regulation and relevance for cardiovascular pathophysiology Am J Physiol 287 2004 R1014 R1030
26. L Li, GD Fink, and SW Watts Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension Circulation 107 2003 1053 1058
27. JQ Liu, IN Zelko, and RJ Folz Reoxygenation-induced constriction in murine coronary arteries: The role of endothelial NADPH oxidase and intracellular superoxide J Biol Chem 279 2004 24493 24497
28. T Marumo, VB Schini-Kerth, and RP Brandes Glucocorticoids inhibit superoxide anion production and p22phox mRNA expression in human aortic smooth muscle cells Hypertension 32 1998 1083 1088
29. JS McNally, ME Davis, DP Giddens, and A Saha Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress Am J Physiol 285 2003 H2290 H2297
30. JD Morrow, and LJ Roberts The isoprostanes: Their role as an index of oxidant stress status in human pulmonary disease Am J Respir Crit Care Med 166 2002 S25 S30
31. 2α a new and independent predictor of peripheral arterial disease J Vasc Surg 40 2004 768 773
32. S Muzaffar, JY Jeremy, and GD Angelini The role of the endothelium and nitric oxide synthases in modulating superoxide formation induced by endotoxin and cytokines in porcine pulmonary arteries Thorax 58 2003 598 604
33. 2α and cytokines Br J Pharmacol 141 2004 488 496
34. phox induced by endotoxin and cytokines in pig pulmonary artery vascular smooth muscle cells and endothelial cells Circulation 110 2004 1140 1147
35. phox expression in pulmonary artery endothelial cells Br J Pharmacol 146 2005 109 117
36. S Muzaffar, N Shukla, GD Angelini, and JY Jeremy Prednisolone augments superoxide formation in porcine pulmonary artery endothelial cells through upregulation of NADPH oxidase Br J Pharmacol 145 2005 688 697
37. phox and endothelial nitric oxide synthase in the pulmonary artery Thorax 60 2005 305 313
38. S Muzaffar, N Shukla, GD Angelini, and JY Jeremy Superoxide augments superoxide formation through upregulation of NADPH oxidase expression (abstr) Br J Pharmacol 2005 www.pa2online.org/Vol2Issue4abst017P.html
39. FE Rey, XC Li, and OA Carratero Perivascular superoxide anion contributes to impairment of endothelium-dependent relaxation: Role of gp91(phox) Circulation 106 2002 2497 2502
40. N Shukla, GD Angelini, and I Wan Potential role of nitroaspirins in the treatment of vein graft failure Ann Thorac Surg 75 2003 1437 1442
41. N Shukla, A Koupparis, and R Persad Inhibitory effect of hyperhomocysteinaemia on relaxation of the aorta of the rabbit is reversed with penicillamine Br J Pharmacol 2005 www.pa2online.org/Vol2Issue4abst129P.html
42. N Shukla, R Jones, and R Persad Hypercholesterolaemia and erectile dysfunction: Role of superoxide generating enzymes and effect of a NO donating sildenafil derivative, NCX 911 Eur J Pharmacol 517 2005 224 231
43. V Ullrich, MH Zou, and M Bachsmid New physiological and pathophysiological aspects on the thromboxane A(2)-prostacyclin regulatory system Biochim Biophys Acta 1532 2001 1 14
44. M Ushio-Fukai, Y Tang, and T Fukai Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis Circ Res 91 2002 1160 1167
45. JL Wallace, LJ Ignarro, and S Fiorucci Potential cardioprotective actions of NO-releasing aspirin Nat Rev Drug Discov 1 2002 375 382
46. H Zhang, A Schmeiber, and CD Garlichs Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: Role of membrane-bound NADH-/NADPH-oxidases Cardiovasc Res 44 1999 215 222